STOCK TITAN

Exxon Mobil Financials

XOM
Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Exxon Mobil (XOM) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 19 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 44 / 100
Financial Profile 44/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Growth
25

Exxon Mobil's revenue declined 5% year-over-year, from $349.6B to $332.2B. This contraction results in a growth score of 25/100.

Leverage
99

Exxon Mobil carries a low D/E ratio of 0.13, meaning only $0.13 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 99/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
18

Exxon Mobil's current ratio of 1.15 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 18/100, which could limit financial flexibility.

Cash Flow
43

Exxon Mobil has a free cash flow margin of 7.1%, earning a moderate score of 43/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns
36

Exxon Mobil's ROE of 11.1% shows moderate profitability relative to equity, earning a score of 36/100. This is down from 12.8% the prior year.

Piotroski F-Score Neutral
5/9

Exxon Mobil passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed
1.80x

For every $1 of reported earnings, Exxon Mobil generates $1.80 in operating cash flow ($52.0B OCF vs $28.8B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$332.2B
YoY-5.0%
5Y CAGR+12.9%
10Y CAGR+3.3%

Exxon Mobil generated $332.2B in revenue in fiscal year 2025. This represents a decrease of 5.0% from the prior year.

EBITDA
N/A
Net Income
$28.8B
YoY-14.4%
10Y CAGR+6.0%

Exxon Mobil reported $28.8B in net income in fiscal year 2025. This represents a decrease of 14.4% from the prior year.

EPS (Diluted)
$6.70
YoY-14.5%
10Y CAGR+5.7%

Exxon Mobil earned $6.70 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 14.5% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$23.6B
YoY-23.1%
10Y CAGR+19.9%

Exxon Mobil generated $23.6B in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 23.1% from the prior year.

Cash & Debt
$10.7B
YoY-53.6%
5Y CAGR+19.6%
10Y CAGR+11.2%

Exxon Mobil held $10.7B in cash against $34.2B in long-term debt as of fiscal year 2025.

Dividends Per Share
$4.00
YoY+4.2%
5Y CAGR+2.8%
10Y CAGR+3.3%

Exxon Mobil paid $4.00 per share in dividends in fiscal year 2025. This represents an increase of 4.2% from the prior year.

Shares Outstanding
4.17B
YoY-4.0%
5Y CAGR-0.3%
10Y CAGR+0.0%

Exxon Mobil had 4.17B shares outstanding in fiscal year 2025. This represents a decrease of 4.0% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
8.7%
YoY-0.9pp
5Y CAGR+21.0pp
10Y CAGR+2.0pp

Exxon Mobil's net profit margin was 8.7% in fiscal year 2025, showing the share of revenue converted to profit. This is down 0.9 percentage points from the prior year.

Return on Equity
11.1%
YoY-1.7pp
5Y CAGR+25.4pp
10Y CAGR+1.7pp

Exxon Mobil's ROE was 11.1% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 1.7 percentage points from the prior year.

Capital Allocation

R&D Spending
$1.2B
YoY+20.0%
5Y CAGR+3.4%
10Y CAGR+1.8%

Exxon Mobil invested $1.2B in research and development in fiscal year 2025. This represents an increase of 20.0% from the prior year.

Share Buybacks
$20.3B
YoY+3.3%
5Y CAGR+118.7%
10Y CAGR+17.5%

Exxon Mobil spent $20.3B on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 3.3% from the prior year.

Capital Expenditures
$28.4B
YoY+16.7%
5Y CAGR+10.4%
10Y CAGR+0.7%

Exxon Mobil invested $28.4B in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 16.7% from the prior year.

XOM Income Statement

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Revenue $82.3B-3.5% $85.3B+4.6% $81.5B-2.0% $83.1B-0.4% $83.4B-7.3% $90.0B-3.3% $93.1B+12.0% $83.1B
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $3.0B-0.1% $3.0B+19.9% $2.5B-0.5% $2.5B-2.9% $2.6B+14.0% $2.3B-10.6% $2.6B+2.9% $2.5B
Operating Income N/A N/A N/A N/A N/A N/A N/A N/A
Interest Expense $163.0M+81.1% $90.0M-37.9% $145.0M-29.3% $205.0M-31.0% $297.0M+43.5% $207.0M-23.6% $271.0M+22.6% $221.0M
Income Tax $1.4B-55.1% $3.2B-5.6% $3.4B-6.1% $3.6B+92.0% $1.9B-54.2% $4.1B-1.0% $4.1B+7.7% $3.8B
Net Income $6.5B-13.9% $7.5B+6.6% $7.1B-8.2% $7.7B+1.4% $7.6B-11.6% $8.6B-6.8% $9.2B+12.4% $8.2B
EPS (Diluted) N/A $1.76+7.3% $1.64-6.8% $1.76 N/A $1.92-10.3% $2.14+3.9% $2.06

XOM Balance Sheet

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Total Assets $449.0B-1.2% $454.3B+1.5% $447.6B-1.0% $451.9B-0.3% $453.5B-1.8% $461.9B+0.3% $460.7B+21.9% $377.9B
Current Assets $83.4B-5.8% $88.5B+4.0% $85.1B-6.7% $91.2B-0.8% $92.0B-2.5% $94.3B-2.0% $96.2B-3.2% $99.4B
Cash & Equivalents $10.7B-22.7% $13.8B-3.7% $14.4B-15.8% $17.0B-26.0% $23.0B-14.5% $26.9B+1.8% $26.5B-20.6% $33.3B
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable $35.7B N/A N/A N/A $35.3B N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $182.4B-2.0% $186.1B+4.8% $177.6B-2.5% $182.1B-0.4% $182.9B-1.4% $185.5B+0.6% $184.4B+11.9% $164.9B
Current Liabilities $72.3B-7.1% $77.8B+14.2% $68.2B-7.7% $73.8B+5.0% $70.3B+0.4% $70.0B-1.1% $70.8B-1.6% $71.9B
Long-Term Debt $34.2B+4.3% $32.8B-2.2% $33.6B+2.3% $32.8B-10.7% $36.8B-0.4% $36.9B+1.0% $36.6B+13.5% $32.2B
Total Equity $259.4B-0.5% $260.6B-0.8% $262.6B0.0% $262.7B-0.4% $263.7B-1.8% $268.6B+0.1% $268.4B+30.8% $205.3B
Retained Earnings $482.5B+0.4% $480.4B+0.7% $477.1B+0.6% $474.3B+0.7% $470.9B+0.7% $467.7B+0.9% $463.3B+1.1% $458.3B

XOM Cash Flow Statement

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Operating Cash Flow $12.7B-14.3% $14.8B+28.0% $11.6B-10.8% $13.0B+5.9% $12.2B-30.4% $17.6B+66.4% $10.6B-28.0% $14.7B
Capital Expenditures $7.5B-14.6% $8.7B+38.9% $6.3B+6.5% $5.9B-13.7% $6.8B+11.0% $6.2B-1.2% $6.2B+22.9% $5.1B
Free Cash Flow $5.2B-13.7% $6.1B+15.1% $5.3B-25.3% $7.1B+30.8% $5.4B-52.7% $11.4B+163.8% $4.3B-54.9% $9.6B
Investing Cash Flow -$7.1B+15.9% -$8.5B-37.2% -$6.2B-49.5% -$4.1B+2.8% -$4.3B+31.9% -$6.2B-28.2% -$4.9B-6.4% -$4.6B
Financing Cash Flow -$8.7B-8.1% -$8.1B+6.9% -$8.7B+36.0% -$13.6B-21.9% -$11.1B-0.3% -$11.1B+11.6% -$12.6B-57.3% -$8.0B
Dividends Paid $4.4B+2.9% $4.2B-1.1% $4.3B-1.1% $4.3B-0.8% $4.4B+3.1% $4.2B-1.1% $4.3B+12.5% $3.8B
Share Buybacks $5.4B+4.9% $5.1B+3.3% $5.0B+3.3% $4.8B-16.9% $5.8B+4.9% $5.5B+3.5% $5.3B+76.9% $3.0B

XOM Financial Ratios

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin 7.9%-0.9pp 8.8%+0.2pp 8.7%-0.6pp 9.3%+0.2pp 9.1%-0.4pp 9.6%-0.4pp 9.9%+0.0pp 9.9%
Return on Equity 2.5%-0.4pp 2.9%+0.2pp 2.7%-0.2pp 2.9%+0.1pp 2.9%-0.3pp 3.2%-0.2pp 3.4%-0.6pp 4.0%
Return on Assets 1.5%-0.2pp 1.7%+0.1pp 1.6%-0.1pp 1.7%+0.0pp 1.7%-0.2pp 1.9%-0.2pp 2.0%-0.2pp 2.2%
Current Ratio 1.15+0.0 1.14-0.1 1.25+0.0 1.24-0.1 1.31-0.0 1.35-0.0 1.36-0.0 1.38
Debt-to-Equity 0.130.0 0.130.0 0.130.0 0.12-0.0 0.140.0 0.140.0 0.14-0.0 0.16
FCF Margin 6.3%-0.8pp 7.1%+0.6pp 6.5%-2.0pp 8.5%+2.0pp 6.5%-6.2pp 12.7%+8.0pp 4.7%-6.9pp 11.5%

Similar Companies

Frequently Asked Questions

Exxon Mobil (XOM) reported $332.2B in total revenue for fiscal year 2025. This represents a -5.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Exxon Mobil (XOM) revenue declined by 5% year-over-year, from $349.6B to $332.2B in fiscal year 2025.

Yes, Exxon Mobil (XOM) reported a net income of $28.8B in fiscal year 2025, with a net profit margin of 8.7%.

Exxon Mobil (XOM) reported diluted earnings per share of $6.70 for fiscal year 2025. This represents a -14.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

As of fiscal year 2025, Exxon Mobil (XOM) had $10.7B in cash and equivalents against $34.2B in long-term debt.

Exxon Mobil (XOM) had a net profit margin of 8.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Exxon Mobil (XOM) paid $4.00 per share in dividends during fiscal year 2025.

Exxon Mobil (XOM) has a return on equity of 11.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Exxon Mobil (XOM) generated $23.6B in free cash flow during fiscal year 2025. This represents a -23.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Exxon Mobil (XOM) generated $52.0B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Exxon Mobil (XOM) had $449.0B in total assets as of fiscal year 2025, including both current and long-term assets.

Exxon Mobil (XOM) invested $28.4B in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Exxon Mobil (XOM) invested $1.2B in research and development during fiscal year 2025.

Yes, Exxon Mobil (XOM) spent $20.3B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Exxon Mobil (XOM) had 4.17B shares outstanding as of fiscal year 2025.

Exxon Mobil (XOM) had a current ratio of 1.15 as of fiscal year 2025, which is considered adequate.

Exxon Mobil (XOM) had a debt-to-equity ratio of 0.13 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Exxon Mobil (XOM) had a return on assets of 6.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Exxon Mobil (XOM) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Exxon Mobil (XOM) has an earnings quality ratio of 1.80x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Exxon Mobil (XOM) scores 44 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top